Inflammatory demyelinating diseases of the central nervous system
Inflammatory demyelinating diseases of the central nervous system are a group of conditions characterized by inflammation and damage to the protective covering of nerve fibers, known as myelin, in the central nervous system (CNS). This group of diseases includes conditions such as multiple sclerosis (MS), neuromyelitis optica (NMO), and acute disseminated encephalomyelitis (ADEM).
Overview
Inflammatory demyelinating diseases occur when the body's immune system mistakenly attacks the myelin sheath, leading to inflammation and damage. This damage disrupts the normal flow of electrical impulses along the nerves, leading to a range of neurological symptoms.
Types of Inflammatory Demyelinating Diseases
There are several types of inflammatory demyelinating diseases, including:
- Multiple sclerosis (MS): This is the most common type of inflammatory demyelinating disease. It is a chronic condition that can cause symptoms such as fatigue, difficulty walking, numbness or tingling, muscle weakness, and problems with coordination and balance.
- Neuromyelitis optica (NMO): Also known as Devic's disease, NMO is a severe disorder that primarily affects the optic nerves and spinal cord.
- Acute disseminated encephalomyelitis (ADEM): ADEM is a rare autoimmune disease marked by a sudden, widespread attack of inflammation in the brain and spinal cord.
Symptoms
The symptoms of inflammatory demyelinating diseases can vary widely, depending on the specific disease and the areas of the CNS affected. Common symptoms can include:
- Fatigue
- Difficulty walking
- Numbness or tingling
- Muscle weakness
- Problems with coordination and balance
- Blurred or double vision
- Problems with bladder or bowel control
Diagnosis
Diagnosis of inflammatory demyelinating diseases typically involves a combination of medical history, physical examination, and diagnostic tests such as magnetic resonance imaging (MRI), lumbar puncture (also known as a spinal tap), and blood tests.
Treatment
Treatment for inflammatory demyelinating diseases generally involves managing symptoms and slowing the progression of the disease. This can include medications to reduce inflammation and manage symptoms, physical therapy to improve mobility and strength, and lifestyle changes to improve overall health.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
